SG11201702320WA - Antitumor drug comprising beta-cyclodextrin - Google Patents

Antitumor drug comprising beta-cyclodextrin

Info

Publication number
SG11201702320WA
SG11201702320WA SG11201702320WA SG11201702320WA SG11201702320WA SG 11201702320W A SG11201702320W A SG 11201702320WA SG 11201702320W A SG11201702320W A SG 11201702320WA SG 11201702320W A SG11201702320W A SG 11201702320WA SG 11201702320W A SG11201702320W A SG 11201702320WA
Authority
SG
Singapore
Prior art keywords
cyclodextrin
beta
antitumor drug
antitumor
drug
Prior art date
Application number
SG11201702320WA
Other languages
English (en)
Inventor
Ryuji Yamaguchi
Guy Perkins
Original Assignee
Jrc G K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jrc G K filed Critical Jrc G K
Publication of SG11201702320WA publication Critical patent/SG11201702320WA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/724Cyclodextrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11201702320WA 2014-09-25 2015-09-24 Antitumor drug comprising beta-cyclodextrin SG11201702320WA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462054993P 2014-09-25 2014-09-25
US201562106236P 2015-01-22 2015-01-22
PCT/JP2015/076956 WO2016047697A1 (ja) 2014-09-25 2015-09-24 β-シクロデキストリンを含む抗腫瘍剤

Publications (1)

Publication Number Publication Date
SG11201702320WA true SG11201702320WA (en) 2017-04-27

Family

ID=55581219

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201702320WA SG11201702320WA (en) 2014-09-25 2015-09-24 Antitumor drug comprising beta-cyclodextrin

Country Status (6)

Country Link
US (1) US20170296573A1 (ja)
EP (1) EP3199166B1 (ja)
JP (1) JP6034542B2 (ja)
SG (1) SG11201702320WA (ja)
TW (1) TW201617084A (ja)
WO (1) WO2016047697A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200000840A1 (en) * 2016-03-20 2020-01-02 Asdera Llc Use of cyclodextrins to reduce endocytosis in malignant and neurodegenerative disorders
AU2018342135A1 (en) * 2017-08-28 2020-04-16 Asdera Llc Use of cyclodextrins in diseases and disorders involving phospholipid dysregulation
KR20200107927A (ko) 2017-09-28 2020-09-16 아스데라 엘엘씨 인지질 조절장애를 수반하는 질환 및 장애에서의 시클로덱스트린의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6553994A (en) * 1993-03-31 1994-10-24 Trustees Of The University Of Pennsylvania, The Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor
WO2014087778A1 (ja) * 2012-12-07 2014-06-12 国立大学法人熊本大学 ヒドロキシアルキル化シクロデキストリンを含む腫瘍細胞選択的抗がん剤

Also Published As

Publication number Publication date
US20170296573A1 (en) 2017-10-19
EP3199166A4 (en) 2018-06-06
JP6034542B2 (ja) 2016-11-30
EP3199166A1 (en) 2017-08-02
TW201617084A (zh) 2016-05-16
JPWO2016047697A1 (ja) 2017-04-27
WO2016047697A1 (ja) 2016-03-31
EP3199166B1 (en) 2019-09-11

Similar Documents

Publication Publication Date Title
ZA201704297B (en) Pyrrolobenzodiazepine-antibody conjugates
HUE055424T2 (hu) Antitest-fynomer konjugátumok
PL3148591T3 (pl) Koniugaty nanocząstka-lek
GB201614443D0 (en) Targeted drug conjugates
EP3246047A4 (en) Combination drug
HUE052701T2 (hu) Gyógyszeradagoló eszközök
GB201613878D0 (en) Complexes
GB201412824D0 (en) Nanoparticles
GB201504771D0 (en) Complexes
SG11201702320WA (en) Antitumor drug comprising beta-cyclodextrin
IL249585A0 (en) providing epi
EP3338805A4 (en) Drug complex
GB2528654B (en) Drug dispenser assembly
IL250160A0 (en) medicinal substance
GB201508480D0 (en) Cancer
EP3111944A4 (en) Antiviral drug
EP3096691C0 (fr) Catheter
GB201408176D0 (en) Ligand drug conjugates
GB201419996D0 (en) Targeted drug conjugates
GB201418984D0 (en) Novel drug conjugates
AP00817S1 (en) Soother
GB201407533D0 (en) Targeted drug conjugates
GB201419994D0 (en) Small molecule drug conjugates
GB201413986D0 (en) Saline drug
GB201401818D0 (en) Targeted drug conjugates